Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy J Wisdom

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
The Journal of Clinical Investigation|May 18, 2023
Atrx deletion impairs CGAS/STING signaling and increases sarcoma response to radiation and oncolytic herpesvirusWarren Floyd, Matthew Pierpoint, Chang Su, et al.
International Journal of Radiation Oncology, Biology, Physics|January 6, 2024
The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific PerspectivesAmy J Wisdom, Christopher A Barker, Joe Y Chang, et al.
Molecular Cancer Therapeutics|February 14, 2018
Characterizing the Potency and Impact of Carbon Ion Therapy in a Primary Mouse Model of Soft Tissue SarcomaJeremy M Brownstein, Amy J Wisdom, Katherine D Castle, et al.
Journal for Immunotherapy of Cancer|October 12, 2022
Tripartite antigen-agnostic combination immunotherapy cures established poorly immunogenic tumorsSven Borchmann, Carolin Selenz, Mia Lohmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2019
Neutrophils promote tumor resistance to radiation therapyAmy J Wisdom, Cierra S Hong, Alexander J Lin, et al.
International Journal of Radiation Oncology, Biology, Physics|October 2, 2024
Setting the Stage: Feasibility and Baseline Characteristics in the PARTIQoL Trial Comparing Proton Therapy Versus Intensity Modulated Radiation Therapy for Localized Prostate CancerAmy J Wisdom, Beow Y Yeap, Jeff M Michalski, et al.
JCI Insight|August 12, 2024
Enhancing radiotherapy response via intratumoral injection of a TLR9 agonist in autochthonous murine sarcomasChang Su, Collin L Kent, Matthew Pierpoint, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Enhancing radiotherapy response via intratumoral injection of the TLR9 agonist CpG to stimulate CD8 T cells in an autochthonous mouse model of sarcomaChang Su, Collin L Kent, Matthew Pierpoint, et al.
Nature Communications|December 18, 2020
Single cell analysis reveals distinct immune landscapes in transplant and primary sarcomas that determine response or resistance to immunotherapyAmy J Wisdom, Yvonne M Mowery, Cierra S Hong, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
The Journal of Clinical Investigation|May 18, 2023
Atrx deletion impairs CGAS/STING signaling and increases sarcoma response to radiation and oncolytic herpesvirusWarren Floyd, Matthew Pierpoint, Chang Su, et al.
International Journal of Radiation Oncology, Biology, Physics|January 6, 2024
The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific PerspectivesAmy J Wisdom, Christopher A Barker, Joe Y Chang, et al.
Molecular Cancer Therapeutics|February 14, 2018
Characterizing the Potency and Impact of Carbon Ion Therapy in a Primary Mouse Model of Soft Tissue SarcomaJeremy M Brownstein, Amy J Wisdom, Katherine D Castle, et al.
Journal for Immunotherapy of Cancer|October 12, 2022
Tripartite antigen-agnostic combination immunotherapy cures established poorly immunogenic tumorsSven Borchmann, Carolin Selenz, Mia Lohmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2019
Neutrophils promote tumor resistance to radiation therapyAmy J Wisdom, Cierra S Hong, Alexander J Lin, et al.
International Journal of Radiation Oncology, Biology, Physics|October 2, 2024
Setting the Stage: Feasibility and Baseline Characteristics in the PARTIQoL Trial Comparing Proton Therapy Versus Intensity Modulated Radiation Therapy for Localized Prostate CancerAmy J Wisdom, Beow Y Yeap, Jeff M Michalski, et al.
JCI Insight|August 12, 2024
Enhancing radiotherapy response via intratumoral injection of a TLR9 agonist in autochthonous murine sarcomasChang Su, Collin L Kent, Matthew Pierpoint, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Enhancing radiotherapy response via intratumoral injection of the TLR9 agonist CpG to stimulate CD8 T cells in an autochthonous mouse model of sarcomaChang Su, Collin L Kent, Matthew Pierpoint, et al.
Nature Communications|December 18, 2020
Single cell analysis reveals distinct immune landscapes in transplant and primary sarcomas that determine response or resistance to immunotherapyAmy J Wisdom, Yvonne M Mowery, Cierra S Hong, et al.
Pageof 3